Science for a better life

Human-Animal Bond

Do Pets Improve our Health?

Explore Your Topic

Medicinal Plants

New Uses for Ancient Active Substances

Food for the Mind: Micronutrients

Professional Tips

How to make your Lawn more Beautiful

Our Products

Pregnancy Nutrition

The Health of My Baby

Leading Innovation Engine in Agriculture

Bayer Closes Monsanto Acquisition

Treatment of Diseases

Can We Trust Gene Editing?

Learning Our ABC’s About Pollinators

Bayer’s Position

Protection of Biodiversity

Immunotherapies

Unleashing the Immune Response to Cancer

Protecting Patients

Beware of Counterfeits!

Arabica, Robusta & Co.

Where's my Coffee Coming from?

Producing a Beloved Fruit

Two Apples a Day…

High-potency Active Ingredients

“High Potentials” to Combat Diseases

A Text message Against Hunger

New Therapy Approaches

Treating Hemophilia with Gene Surgery

Bayer Corporate Blog

How Self-care Helped Save my Life

Bayer Corporate Blog

A Strong Brand Can’t Rest on its Laurels

Meet our Scientists

Here's How to Improve Photosynthesis in Plants

Bayer Annual Report 2017

Business at prior-year level - on track with strategy

Fighting Cancer

Gaining Time

Challenges in Agriculture

Two Farmers, Two Worlds

Extra Protection

Our Skin Needs Special Care

How Special Collars Can Protect Cats & Dogs

Bayer Corporate Blog

"I Found My Calling in Agriculture"

For A Better Life

Our Brand.

The Virus Fighter

Novel Therapies

Small Molecules to Treat Cancer

Working at Bayer

An Exciting Place for Engineers

Food Production

Stopping Crop Losses

How Is Bayer Responding to Climate Change?

Combating Parasites in the Beehive

Oncology Research

Fighting Cancer

Future of Agriculture

Smart Fields

Cancer Therapies

A Few Months Can Be Worth A Lot

What Is Bayer’s Position on Genetic Engineering?

Support For Smallholder Farmers

Bayer & NGOs Collaborate

Controlling Cells with Light Signals

Links

Latest News

Share Price / Index

June 19, 2018

Bayer concludes refinancing of the Monsanto acquisition by placing bonds with a volume of 5 billion euros

June 19, 2018

Bayer issues new bonds with a volume of 15 billion U.S. dollars

June 7, 2018

Bayer closes Monsanto acquisition

Advance Your Career

Why Bayer

Working at Bayer

Meet Our Employees

Open Jobs

Explore Our Businesses

We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here.

Pharmaceuticals

Read more

Consumer Health

Read more

Crop Science

Read more

Animal Health

Read more

Find Your Product

With our products we contribute to the health of people, animals and plants. Here you find an overview of the major Bayer products.

A

Z

Can We Live Better?

Challenges of a Better Tomorrow

Aging Population, big data, prenatal nutrition, water scarcity, animal-human bond: Bayer engages in a conversation about the future that matters the most to you – your own.

Last updated: June 19, 2018